- Home
- WKSP vs INAB Comparison
WKSP vs INAB Comparison
Compare WKSP & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- INAB
- Stock Information
- Founded
- WKSP 2003
- INAB 2016
- Country
- WKSP United States
- INAB United States
- Employees
- WKSP N/A
- INAB N/A
- Industry
- WKSP Auto Parts:O.E.M.
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- INAB Health Care
- Exchange
- WKSP Nasdaq
- INAB Nasdaq
- Market Cap
- WKSP 14.7M
- INAB 14.5M
- IPO Year
- WKSP N/A
- INAB 2021
- Fundamental
- Price
- WKSP $3.04
- INAB $0.12
- Analyst Decision
- WKSP Strong Buy
- INAB Strong Buy
- Analyst Count
- WKSP 3
- INAB 2
- Target Price
- WKSP $12.83
- INAB $3.60
- AVG Volume (30 Days)
- WKSP 333.2K
- INAB 7.9M
- Earning Date
- WKSP 05-15-2025
- INAB 05-07-2025
- Dividend Yield
- WKSP N/A
- INAB N/A
- EPS Growth
- WKSP N/A
- INAB N/A
- EPS
- WKSP N/A
- INAB N/A
- Revenue
- WKSP $10,211,747.00
- INAB N/A
- Revenue This Year
- WKSP $159.92
- INAB N/A
- Revenue Next Year
- WKSP $68.25
- INAB N/A
- P/E Ratio
- WKSP N/A
- INAB N/A
- Revenue Growth
- WKSP 407.96
- INAB N/A
- 52 Week Low
- WKSP $2.44
- INAB $0.10
- 52 Week High
- WKSP $12.00
- INAB $1.74
- Technical
- Relative Strength Index (RSI)
- WKSP 50.64
- INAB 33.67
- Support Level
- WKSP $2.46
- INAB $0.10
- Resistance Level
- WKSP $3.03
- INAB $0.19
- Average True Range (ATR)
- WKSP 0.28
- INAB 0.02
- MACD
- WKSP 0.06
- INAB -0.00
- Stochastic Oscillator
- WKSP 59.90
- INAB 22.21
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.